A boost from COVID-19 treatment sales helped bush Pfizer to a better-than-expected third quarter and higher forecast for the year.

Paxlovid can prevent hospitalization and death from COVID-19, but experts say it's being underused.

Pfizer lost more than $2 billion in the third quarter as an expected COVID-19 product sales decline clipped revenue.

The COVID-19 treatments millions of have taken for free from the federal government will enter the private market next week with a hefty price tag.

Crumbling COVID-19 vaccine and treatment sales chopped Pfizer’s second-quarter earnings, but both the drugmaker and Wall Street expect a rebound in the back half of 2023.

U.S. health regulators have given full approval to Pfizer’s COVID-19 pill Paxlovid.

U.S. health advisersare backing the continued use of Pfizer’s COVID-19 pill Paxlovid, saying it remains an important option for adults at high risk of severe illness.

Pfizer surprised Wall Street on Tuesday by predicting bigger-than-expected sales drops this year for two key products: its COVID-19 vaccine and treatment.

China will not include Pfizer’s COVID-19 treatment drug in a national reimbursement list that would have allowed patients to get it at a cheaper price, saying it was too expensive.

The Washtenaw County Health Department announced on Tuesday a new COVID-19 program for residents without health insurance or access to a health care provider.

Pfizer’s COVID-19 pill appears to provide little or no benefit for younger adults.

President Joe Biden's doctor says the 79-year-old president has tested negative for COVID-19 but will continue to isolate at the White House until a second negative test.

President Joe Biden's physician, Dr. Kevin O'Connor, says Biden continues to “improve significantly” despite a lingering sore throat.

President Joe Biden is reporting a runny nose, fatigue and an occasional dry cough from his COVID-19 infection.

U.S. pharmacists can now prescribe the leading COVID-19 pill directly to patients.

The White House has announced more steps to make the antiviral treatment Paxlovid more accessible across the U.S. as it projects COVID-19 infections will continue to spread over the summer travel season.

The head of the World Health Organization has called on Pfizer to make its COVID-19 treatment more widely available in poorer countries.

A small number of COVID-19 patients are relapsing after taking Pfizer's antiviral pill, raising questions about the drug at the center of the U.S. response effort.

COVID-19 patients have two treatment options that can be taken at home.

President Joe Biden’s administration is taking steps to expand availability of the life-saving COVID-19 antiviral treatment Paxlovid.

President Joe Biden and his administration want Americans and their doctors to know that the country has an ample supply of the life-saving COVID-19 antiviral treatment Paxlovid and that it no longer needs to be rationed.

COVID-19 patients now have new treatments they can take at home to stay out of the hospital — if doctors get the pills to them fast enough.

Many people want to know what to expect next as we enter the third year of the COVID pandemic.

The White House launched its “test to treat” COVID initiative on Monday.

Pfizer’s new COVID-19 treatment came with a catch when it debuted late last year: It can take months to make the tablets.

COVID-19 vaccine sales boosted Pfizer earnings well past fourth-quarter expectations, but the drugmaker has set a lower-than-expected bar for 2022.

South Korea has received its first supply of Pfizer’s antiviral COVID-19 pills to treat patients with mild or moderate symptoms.

Michigan health officials say the state has received its first shipment of newly authorized COVID-19 pill treatments, but it’ll only be prescribed in certain situations due to limited supply.

Israel has approved a fourth vaccine dose for people most vulnerable to COVID-19, becoming one of the first countries to do so as it braces for a wave of infections fueled by the omicron variant.

Newly infected COVID-19 patients have two new treatment options that can be taken at home.

Two antiviral pills are the latest additions to the handful of therapies to treat COVID-19 in the U.S. The Food and Drug Administration authorized the drugs from Merck and Pfizer as the first treatments that patients can take at home to treat mild-to-moderate symptoms.

The U.S. has authorized the first pill against COVID-19, a Pfizer drug that Americans can take at home to reduce the risk of hospitalization and death.